Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12 — Class II drug recall D-0532-2025
Ongoing recall by Lupin Pharmaceuticals Inc., reported 2025-07-23, distributed nationwide. Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinop
| Recall number | D-0532-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Naples, FL, United States |
| Recall initiated | 2025-06-20 |
| Classified | 2025-07-17 |
| Reported by FDA | 2025-07-23 |
| Distributed | Nationwide (US) |
| Quantity | 58,968 bottles |
| NDC | 68180-0518, 68180-0518-01, 68180-0518-02, 68180-0518-30, 68180-0519, 68180-0519-01, 68180-0519-02, 68180-0519-30, 68180-0520, 68180-0520-01, 68180-0520-02, 68180-0520-30 |
| Lot numbers | QA01081 |
| Expiration dates | 2027-04-20 |
Product
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01
Reason for recall
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0532-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.